Jamie L. Bascom, Ph.D.
Affiliations: | 2006 | University of California, Berkeley, Berkeley, CA, United States |
Area:
Microenvironmental Influences on Gene Expression and Tissue Specificity in Normal and Malignant BreastGoogle:
"Jamie Bascom"Mean distance: 9.82 | S | N | B | C | P |
Parents
Sign in to add mentorMina J. Bissell | grad student | 2006 | UC Berkeley | |
(Elucidation of the role of epimorphin/syntaxin-2 in mouse mammary gland development and mammary cancer.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Bascom JL, Radisky DC, Koh E, et al. (2013) Epimorphin is a novel regulator of the progesterone receptor isoform-a. Cancer Research. 73: 5719-29 |
Mori H, Lo AT, Inman JL, et al. (2013) Transmembrane/cytoplasmic, rather than catalytic, domains of Mmp14 signal to MAPK activation and mammary branching morphogenesis via binding to integrin β1. Development (Cambridge, England). 140: 343-52 |
Dusek RL, Bascom JL, Vogel H, et al. (2012) Deficiency of the p53/p63 target Perp alters mammary gland homeostasis and promotes cancer. Breast Cancer Research : Bcr. 14: R65 |
Andersen K, Mori H, Fata J, et al. (2011) The metastasis-promoting protein S100A4 regulates mammary branching morphogenesis Developmental Biology. 352: 181-190 |
Rizki A, Weaver VM, Lee SY, et al. (2008) A human breast cell model of preinvasive to invasive transition. Cancer Research. 68: 1378-87 |
Bascom JL, Fata JE, Hirai Y, et al. (2005) Epimorphin overexpression in the mouse mammary gland promotes alveolar hyperplasia and mammary adenocarcinoma. Cancer Research. 65: 8617-21 |
Bascom JL, Kenny PA. (2005) Keystone symposium: the role of microenvironment in tumor induction and progression, Banff, Canada, 5-10 February 2005. Breast Cancer Research : Bcr. 7: 113-8 |
Novaro V, Bascom JL, Liu H, et al. (2003) Department of Defense Era of Hope meeting, Orlando, Florida, USA, 25-28 September 2002. Breast Cancer Research : Bcr. 5: 53-6 |